首页> 外国专利> 4-(4-chlorophenylsulphonylcarbamoyl) benzoyl-L-valyl- L-proline 1(RS)-(1-trifluoroacetyl-2-methylpropyl)amide for use in treating haemorrhage associated with acute non-lymphocytic leukaemia

4-(4-chlorophenylsulphonylcarbamoyl) benzoyl-L-valyl- L-proline 1(RS)-(1-trifluoroacetyl-2-methylpropyl)amide for use in treating haemorrhage associated with acute non-lymphocytic leukaemia

机译:4-(4-氯苯基磺酰基氨基甲酰基)苯甲酰基-L-戊基-L-脯氨酸1(RS)-(1-三氟乙酰基-2-甲基丙基)酰胺用于治疗急性非淋巴细胞性白血病相关的出血

摘要

The invention includes a novel therapeutic agent comprising 4-(4-chlorophenylsulphonylcarbamoyl)benzoyl-L-valyl-L-proline 1(RS)-(1-trifluoroacetyl-2methylpropyl)amide for use in the prevention or treatment of haemorrhagic conditions associated with acute non-lymphocytic leukaemia or its therapy, the use of this peptide derivative in the manufacture of a medicament for the prevention or treatment of said haemorrhagic conditions, as well as a method of prevention or treatment of said haemorrhagic conditions, as well as a method of prevention or treatment of said haemorrhagic conditions using the peptide derivative.
机译:本发明包括用于预防或治疗与急性相关的出血性疾病的包含4-(4-氯苯基磺酰基氨基甲酰基)苯甲酰基-L-戊酰基-L-脯氨酸1(RS)-(1-三氟乙酰基-2-甲基丙基)酰胺的新型治疗剂。非淋巴细胞性白血病或其治疗,该肽衍生物在制备用于预防或治疗所述出血性疾病的药物中的用途以及预防或治疗所述出血性疾病的方法以及使用肽衍生物预防或治疗所述出血性疾病。

著录项

  • 公开/公告号AU648084B2

    专利类型

  • 公开/公告日1994-04-14

    原文格式PDF

  • 申请/专利权人 IMPERIAL CHEMICAL INDUSTRIES PLC;

    申请/专利号AU19910079241

  • 发明设计人 MITCHELL GLASS;

    申请日1991-06-24

  • 分类号A61K37/02;A61K31/40;

  • 国家 AU

  • 入库时间 2022-08-22 04:41:21

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号